CD22 and hairy cell leukemia: CD22 is also expressed by most B cell malignancies, including leukemic blasts in > 90% patients with B cell ALL, as well as chronic lymphocytic leukemia (CLL), NHL, and hairy cell leukemia (HCL) [72, 73].